Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Cardiovascular Surgery Devices And Equipment Market Expected to Grow Between 2025 And 2029?
The market for cardiovascular surgery devices and equipment has experienced robust growth in recent years. The industry is expected to expand from $1.89 billion in 2024 to $1.99 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. Factors contributing to growth in the historical period include the prevalence of cardiovascular diseases, technological advances, an aging population, and chronic disease management.
What Growth Rate Is Anticipated for the Cardiovascular Surgery Devices And Equipment Market in the Coming Years?
The market for cardiovascular surgery devices and equipment is projected to experience slight expansion in the upcoming years. The market is estimated to reach $2.15 billion by the year 2029, with a compound annual growth rate (CAGR) of 1.9%. Factors contributing to growth in the projection period include the rise of minimally invasive procedures, advancements in imaging technology, personalized medical approaches, telemedicine, and teleconsultations. The forecast period is also expected to see significant trends such as the increase of hybrid operating rooms, the prevalence of transcatheter operations, the application of artificial intelligence (AI) in surgeries, and enhancements in remote surgical education.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp
Who Are the Leading Companies in the Cardiovascular Surgery Devices And Equipment Market?
Major companies operating in the cardiovascular surgery devices and equipment market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., Angiodynamics, Transmedics, Terumo cardiovascular systems corporation, Edwards Life Science Corporation, Medtronic plc, Cardinal Health, Cyberheart Incorporated, Medwaves Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.P.A., Biosensors International, Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., Krdium Inc., SEMMT Inc., Amaranth Medical, 3M Health Care, Abaxis Inc., Atlas Genetics, Becton Dickinson and Company, BioFire Diagnostics, bioMérieux, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, EKF Diagnostics, GenMark Diagnostics, Hologic, LumiraDx, Mesa Biotech (a subsidiary of Thermo Fisher Scientific), Nova Biomedical, NOWDiagnostics, Opko Health, OraSure Technologies, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Trividia Health, Trivitron Healthcare, Werfen S.A.
What Are the Key Drivers of the Cardiovascular Surgery Devices And Equipment Market?
The increase in the elderly population coupled with the escalating mortality rate from cardiovascular ailments is propelling the cardiovascular surgical devices market forward. As per the American Heart Association (AHA), around 43.7 million individuals over 60 years old were plagued with cardiovascular diseases in the United States alone. The AHA further comments that the yearly death toll from heart conditions is at 17.3 million and is projected to escalate to over 23.6 million globally by 2030. This has resulted in a surge in the number of surgeries conducted, consequently catalyzing the market’s expansion.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2389&type=smp
What Are the Key Market Segments in the Cardiovascular Surgery Devices And Equipment Industry?
The cardiovascular surgery devices and equipment market covered in this report is segmented –
1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables
2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications
3) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research Laboratories
Subsegments:
1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices
2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment
3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices
4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables
What Are the Latest Trends in the Cardiovascular Surgery Devices And Equipment Market?
Prominent firms are making investments in businesses that specialize in the Cardiovascular Surgery Devices and Equipment market and who are striving to create revolutionary solutions such as CardioVisio for Atrial Fibrillation (AFib). This is in an effort to boost early detection, augment patient results, and simplify treatment procedures. CardioVisio for Atrial Fibrillation (AFib) is an advanced detection and management solution for AFib, a common irregular heartbeat condition. For example, in August 2023, US-based GE HealthCare, a firm focused on medical technology, introduced CardioVisio for Atrial Fibrillation (AFib). This digital tool assists clinical decisions and is designed to amplify the accuracy of care for AFib patients. Debuted at the ESC Congress 2023, this ground-breaking solution merges longitudinal patient data from diversified sources, granting clinicians a holistic understanding of cardiac health. By presenting recommendations rooted in AFib guidelines, CardioVisio optimizes clinical processes and enhances adherence to top-tier strategies.
Access The Full Report Here:
What Are the Key Regional Markets in the Cardiovascular Surgery Devices And Equipment Industry?
North America was the largest region in the global cardiovascular surgery devices and equipment market in 2023. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2389
This Report Delivers Insight On:
1. How big is the cardiovascular surgery devices and equipment market, and how is it changing globally?
2. Who are the major companies in the cardiovascular surgery devices and equipment market, and how are they performing?
3. What are the key opportunities and risks in the cardiovascular surgery devices and equipment market right now?
4. Which products or customer segments are growing the most in the cardiovascular surgery devices and equipment market?
5. What factors are helping or slowing down the growth of the cardiovascular surgery devices and equipment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
